Items where Author is "Aarabi, M. H."

Article

(2025) Exploring the oxidative mechanism of methotrexate on catalase enzyme: an in vitro study. Free radical research. pp. 1-8. ISSN 1029-2470 (Electronic) 1029-2470 (Linking)

(2024) Astaxanthin prevents nephrotoxicity through Nrf2/HO-1 pathway. Canadian Journal of Physiology and Pharmacology. pp. 128-136. ISSN 0008-4212

(2024) Effect of Saffron (Crocus sativus) Supplementation on Oxidative Stress, Inflammatory Indices, and Renal and Liver Function Parameters in Patients With Type 2 Diabetes Mellitus: A GRADE-Assessed Systematic Review and Meta-analysis of Randomized Clinical Trials. Nutrition Reviews. p. 17. ISSN 0029-6643

(2024) Examining hepatoprotective effects of astaxanthin against methotrexate-induced hepatotoxicity in rats through modulation of Nrf2/HO-1 pathway genes. Naunyn-Schmiedeberg's archives of pharmacology. pp. 371-380. ISSN 1432-1912 (Electronic) 0028-1298 (Linking)

(2024) The beneficial effects of crocin supplementation on metabolic and genetic parameters in type 2 diabetic patients under metformin treatment: A randomized double-blind controlled clinical trial. Journal of Functional Foods. p. 11. ISSN 1756-4646

(2023) ASTAXANTHIN IMPROVES FATTY ACID DYSREGULATION IN DIABETES BY CONTROLLING THE AMPK-SIRT1 PATHWAY. Excli Journal. pp. 502-515. ISSN 1611-2156

(2023) Astaxanthin prevents nephrotoxicity through<i> </i>Nrf2/HO-1 pathway. Canadian Journal of Physiology and Pharmacology. p. 9. ISSN 0008-4212

(2023) Curcumin supplementation prevents cisplatin-induced nephrotoxicity: a randomized, double-blinded, and placebo-controlled trial. Research in Pharmaceutical Sciences. pp. 648-662. ISSN 1735-5362

(2023) Impact of polyphenols on heart failure and cardiac hypertrophy: clinical effects and molecular mechanisms. Frontiers in Cardiovascular Medicine. p. 23. ISSN 2297-055X

(2023) Melatonin and 5-fluorouracil combination chemotherapy: opportunities and efficacy in cancer therapy. Cell Communication and Signaling. p. 17.

(2023) Melatonin targeting non-coding RNAs in cancer: Focus on mechanisms and potential therapeutic targets. European Journal of Pharmacology. p. 10. ISSN 0014-2999

(2023) Possible Mechanisms and Molecular Signaling of Incretins against the Development of Type 2 Diabetes Mellitus. Current Molecular Pharmacology. pp. 448-464. ISSN 1874-4672

(2023) Preparation and characterisation of a new form of silymarin as a potential antidiabetic agent in the adult male rat. Archives of physiology and biochemistry. pp. 799-809. ISSN 1744-4160 (Electronic) 1381-3455 (Linking)

(2023) Supplement astaxanthin affects PPAR-γ/miR-27a axis and metabolic profile. Gene Reports. p. 7.

(2023) Targeting Glioma Cells with Nutraceuticals: Therapeutic Effects Based on Molecular Mechanisms, New Evidence and Perspectives. Mini-Reviews in Medicinal Chemistry. pp. 1167-1192. ISSN 1389-5575

(2023) White matter tracts alterations underpinning reward and conflict processing. Journal of Affective Disorders. pp. 251-258. ISSN 0165-0327

(2023) The effects of astaxanthin on AMPK/autophagy axis and inflammation in type 2 diabetes patients: A randomized, double-blind, placebo-controlled trial. Gene Reports. p. 9.

(2022) Anti-Cancer Effects of Nanoliposomes Containing Rosemary and Zataria multiflora Boiss Essential Oils on Hepg2 Cell Line under in Vitro Conditions. Journal of Babol University of Medical Sciences. pp. 141-150. ISSN 15614107 (ISSN)

(2022) Antioxidant effects of astaxanthin and metformin combined therapy in type 2 diabetes mellitus patients: a randomized double-blind controlled clinical trial. Research in Pharmaceutical Sciences. pp. 219-230. ISSN 1735-5362 (Print) 1735-9414 (Electronic) 1735-5362 (Linking)

(2022) A CB2 Receptor Agonist Reduces the Production of Inflammatory Mediators and Improves Locomotor Activity in Experimental Autoimmune Encephalomyelitis. REPORTS OF BIOCHEMISTRY AND MOLECULAR BIOLOGY. pp. 1-9. ISSN 2322-3480 J9 - REP BIOCHEM MOL BIOL

(2022) Possible mechanisms and molecular signaling of incretins against the development of type 2 diabetes mellitus. Curr Mol Pharmacol. ISSN 1874-4672

(2022) Targeting Glioma Cells with Nutraceuticals: Therapeutic Effects Based on Molecular Mechanisms, New Evidence, and Perspectives. Mini Rev Med Chem. ISSN 1389-5575

(2022) Therapeutic Potential of Resveratrol in Diabetic Nephropathy According to Molecular Signaling. CURRENT MOLECULAR PHARMACOLOGY. pp. 716-735. ISSN 1874-4672 1874-4702 J9 - CURR MOL PHARMACOL

(2021) Anti-osteoarthritis potential of peppermint and rosemary essential oils in a nanoemulsion form: behavioral, biochemical, and histopathological evidence. Bmc Complementary Medicine and Therapies.

(2021) Distinct patterns of hippocampal subfield volume loss in left and right mesial temporal lobe epilepsy. Neurological Sciences. pp. 1411-1421. ISSN 1590-1874

(2021) Preparation and characterisation of a new form of silymarin as a potential antidiabetic agent in the adult male rat. Arch Physiol Biochem. pp. 1-11. ISSN 1381-3455

(2021) Preventive effect of novel nanomissile of silymarin on liver injury induced by carbon tetrachloride in rat. Scientific Journal of Kurdistan University of Medical Sciences. pp. 1-11. ISSN 1560652X (ISSN)

(2017) Effects of Synbiotic Food Consumption on Serum Minerals, Liver Enzymes, and Blood Pressure in Patients with Type 2 Diabetes: A Double-blind Randomized Cross-over Controlled Clinical Trial. International Journal of Preventive Medicine. ISSN 2008-7802